Dexamethasone Phosphate Ophthalmic

DRUG2 trials

Sponsors

Eyegate Pharmaceuticals, Inc.

Conditions

CataractMacular Edema

Phase 1

Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema

TerminatedNCT02485249

Eyegate Pharmaceuticals, Inc.Macular Edema

Start: 2015-07-31End: 2016-06-30Updated: 2016-08-03

Phase 2

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL

CompletedNCT01602068

Eyegate Pharmaceuticals, Inc.Cataract

Start: 2012-05-31End: 2012-10-31Updated: 2019-01-29